Ignite Creation Date:
2024-05-06 @ 12:11 AM
Last Modification Date:
2024-10-26 @ 10:46 AM
Study NCT ID:
NCT01511094
Status:
UNKNOWN
Last Update Posted:
2012-01-18
First Post:
2011-10-14
Brief Title:
Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma Outcomes and Complications
Sponsor:
Federal University of Minas Gerais
Organization:
Federal University of Minas Gerais
Study Overview
Official Title:
Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma Outcomes and Complications
Status:
UNKNOWN
Status Verified Date:
2012-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GC
Brief Summary:
The study has the purpose to evaluate the effectiveness and safety of the goniocurettage as a first choice of surgical treatment for primary open-angle glaucoma POAG in patients with good vision
Detailed Description:
A prospective study in 33 eyes 32 patients with uncontrolled open angle glaucoma under clinical treatment The trabecular tissue was scraped away from the angle goniocurettage in about 100 degrees by means of an instrument similar to a microchalazion curette The goniocurettage was done under direct visualization of the angle through a gonioscopy lens Swan-Jacob and a surgical microscope Using the 170 SPSS software the investigators compared the intraocular pressure the numbers of antiglaucomatous medications the best correct visual acuity the development of cataract the central corneal thicknessthe impact on the visual field the impact on the optic nerve head and the central corneal endothelial cell density before and after the goniocurettage and the intra and post operative complications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None